- Home
- LWAC vs MREO Comparison
LWAC vs MREO Comparison
Compare LWAC & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$0.49
Company Overview
Basic Information| Metric | LWAC | MREO |
|---|---|---|
| Founded | 2025 | 2015 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 301.7M | 324.6M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | LWAC | MREO |
|---|---|---|
| Price | $10.03 | $0.49 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $4.30 |
| AVG Volume (30 Days) | 33.1K | ★ 23.0M |
| Earning Date | 01-01-0001 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $500,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $163.84 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.81 | $0.20 |
| 52 Week High | $10.12 | $3.84 |
Technical Indicators
Market Signals| Indicator | LWAC | MREO |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 26.18 |
| Support Level | N/A | $0.20 |
| Resistance Level | N/A | $2.35 |
| Average True Range (ATR) | 0.00 | 0.13 |
| MACD | 0.00 | -0.22 |
| Stochastic Oscillator | 0.00 | 13.93 |
Price Performance
Historical Comparison LWAC
MREO
About LWAC LightWave Acquisition Corp. Class A Ordinary Shares
LightWave Acquisition Corp is a blank check company.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).